Latest Articles

Publication Date
Ultrasonographic features and ovarian reserve in ovarian endometrioma: Implications for risk stratification.

To investigate the association between ultrasonographic features of ovarian endometrioma (OMA) and diminished ovarian reserve, and to evaluate the predictive value of these ultrasound markers.

Published: June 12, 2026, midnight
PCOS has had a name change – but doctors are still falling behind in treating the hormone imbalance - Yahoo Life UK

PCOS has had a name change – but doctors are still falling behind in treating the hormone imbalance Yahoo Life UK

Published: June 10, 2026, 5 a.m.
Molecular Insights Into Endometriosis for Early Detection and Therapeutic Targets.

Endometriosis is a hormone-dependent chronic inflammatory disease associated with pain and infertility, remains diagnostically and therapeutically challenging due to its multifactorial nature. Molecular mechanisms of the dynamic changes during disease …

Published: June 10, 2026, midnight
Expert opinion on best practice in programmed frozen embryo transfers: a Delphi consensus.

How can outcomes in programmed frozen embryo transfers (FET) be improved, and what are the key areas where more research is needed?

Published: June 10, 2026, midnight
Multiple recurrences of postmenopausal endometriosis associated with estrogen pellet therapy: clinical implications for hormone therapy and surgical management.

To challenge the perception that endometriosis uniformly regresses after menopause by presenting the case of repeated, pathology-confirmed symptomatic recurrences spanning two decades after menopause, and to emphasize key considerations for …

Published: June 9, 2026, midnight
Comparative post-marketing reporting signals of elagolix and myfembree in endometriosis: a FAERS pharmacovigilance study.

Elagolix and Myfembree are gonadotropin-releasing hormone (GnRH)-pathway therapies used for endometriosis, but their post-marketing safety reporting patterns remain incompletely characterized. Because spontaneous reporting databases are susceptible to reporting bias and …

Published: June 5, 2026, midnight
Women ‘blindsided’ as critical hormone therapy pulled from shelves - Herald Sun

Women ‘blindsided’ as critical hormone therapy pulled from shelves Herald Sun

Published: June 4, 2026, 8:38 p.m.
Women ‘blindsided’ as critical hormone therapy pulled from shelves - NT News

Women ‘blindsided’ as critical hormone therapy pulled from shelves NT News

Published: June 4, 2026, 4:21 a.m.
Women ‘blindsided’ as critical hormone therapy pulled from shelves - The Cairns Post

Women ‘blindsided’ as critical hormone therapy pulled from shelves The Cairns Post

Published: June 4, 2026, 4:20 a.m.
RE-1 silencing transcription factor is reduced in endometriosis and uterine deletion in mice alters progesterone responsiveness.

Endometriosis is a steroid-dependent gynecologic disease characterized by progesterone (P4) resistance, subfertility/infertility, and pelvic pain; however, the molecular mechanisms underlying impaired P4 responsiveness in endometriosis tissue are not fully understood. …

Published: June 3, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!